StockData
vTv Therapeutics Inc. logo

vTv Therapeutics Inc. (VTVT) stock

VTVTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3064% below fair value
$16.23−1.06 (-6.13%)

Close on Nov 18, 2026Market cap $64.17MP/E –Yield –

vTv Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

vTv Therapeutics's revenue for the twelve months ending Jun 30, 2026 was $36.84M, up 216600.0% year over year. For fiscal 2025 it was $0, down 100.0% from the year before. The highest annual figure on record is $12.43M in fiscal 2018.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$0-100.0%
FY2024Dec 31, 2024$1.02M–
FY2023Dec 31, 2023$0-100.0%
FY2022Dec 31, 2022$2.02M-49.6%
FY2021Dec 31, 2021$4.01M-37.6%
FY2020Dec 31, 2020$6.41M+132.1%
FY2019Dec 31, 2019$2.76M-77.8%
FY2018Dec 31, 2018$12.43M+4172.9%
FY2017Dec 31, 2017$291.00K-54.1%
FY2016Dec 31, 2016$634.00K+22.2%
FY2015Dec 31, 2015$519.00K-66.5%
FY2014Dec 31, 2014$1.55M+58.7%
FY2013Dec 31, 2013$976.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$0–
Q1 FY2026Mar 31, 2026$36.84M–
Q4 FY2025Dec 31, 2025$0-100.0%
Q3 FY2025Sep 30, 2025$0–
Q2 FY2025Jun 30, 2025$0–
Q1 FY2025Mar 31, 2025$0-100.0%
Q4 FY2024Dec 31, 2024$17.00K–
Q3 FY2024Sep 30, 2024$0–
Q2 FY2024Jun 30, 2024$0–
Q1 FY2024Mar 31, 2024$1.00M–
Q4 FY2023Dec 31, 2023$0-100.0%
Q3 FY2023Sep 30, 2023$0–
Q2 FY2023Jun 30, 2023$0-100.0%
Q1 FY2023Mar 31, 2023$0-100.0%
Q4 FY2022Dec 31, 2022$9.00K0.0%
Q3 FY2022Sep 30, 2022$0-100.0%
Q2 FY2022Jun 30, 2022$9.00K0.0%
Q1 FY2022Mar 31, 2022$2.00M+102.6%
Q4 FY2021Dec 31, 2021$9.00K-99.9%
Q3 FY2021Sep 30, 2021$3.00M+42757.1%
Q2 FY2021Jun 30, 2021$9.00K–
Q1 FY2021Mar 31, 2021$987.00K+12237.5%
Q4 FY2020Dec 31, 2020$6.40M+91314.3%
Q3 FY2020Sep 30, 2020$7.00K-12.5%
Q2 FY2020Jun 30, 2020$0-100.0%
Q1 FY2020Mar 31, 2020$8.00K-99.1%
Q4 FY2019Dec 31, 2019$7.00K-99.8%
Q3 FY2019Sep 30, 2019$8.00K-99.8%
Q2 FY2019Jun 30, 2019$1.83M-26.1%
Q1 FY2019Mar 31, 2019$921.00K-55.4%
Q4 FY2018Dec 31, 2018$4.52M+1840.8%
Q3 FY2018Sep 30, 2018$3.38M+22400.0%
Q2 FY2018Jun 30, 2018$2.47M+18923.1%
Q1 FY2018Mar 31, 2018$2.06M+6780.0%
Q4 FY2017Dec 31, 2017$233.00K+513.2%
Q3 FY2017Sep 30, 2017$15.00K-60.5%
Q2 FY2017Jun 30, 2017$13.00K–
Q1 FY2017Mar 31, 2017$30.00K–
Q4 FY2016Dec 31, 2016$38.00K–
Q3 FY2016Sep 30, 2016$38.00K–

More vTv Therapeutics figures

See a number that looks wrong?